Barclays
MJN

Barclays’s Mead Johnson Nutrition Company MJN Stock Holding History

Barclays’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-881,402
Closed -$78.5M – 7203
2017
Q1 		$78.5M Buy
881,402
+681,629
+341% +$56.1M 0.09% 173
2016
Q4 		$14.1M Buy
199,773
+88,834
+80% +$6.62M 0.02% 776
2016
Q3 		$8.76M Sell
110,939
-35,043
-24% -$2.99M 0.01% 940
2016
Q2 		$13.2M Sell
145,982
-52,120
-26% -$4.41M 0.02% 702
2016
Q1 		$16.6M Buy
198,102
+110,893
+127% +$8.25M 0.03% 546
2015
Q4 		$6.8M Sell
87,209
-22,684
-21% -$1.79M 0.01% 1101
2015
Q3 		$7.69M Sell
109,893
-24,843
-18% -$2.04M 0.01% 1089
2015
Q2 		$12.1M Buy
134,736
+42,585
+46% +$4.11M 0.01% 913
2015
Q1 		$9.22M Sell
92,151
-59,930
-39% -$6.04M 0.01% 1124
2014
Q4 		$15.2M Buy
152,081
+32,091
+27% +$3.2M 0.01% 912
2014
Q3 		$11.5M Sell
119,990
-92,164
-43% -$8.73M 0.01% 1068
2014
Q2 		$19.7M Buy
212,154
+105,860
+100% +$9.26M 0.02% 707
2014
Q1 		$8.82M Sell
106,294
-77,218
-42% -$6.26M 0.01% 1237
2013
Q4 		$15.2M Buy
183,512
+26,303
+17% +$2.14M 0.02% 946
2013
Q3 		$11.6M Buy
157,209
+52,371
+50% +$3.93M 0.01% 1036
2013
Q2 		$8.31M Buy
+104,838
New +$8.41M 0.01% 1215

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Barclays's MJN Position: Q2 2017 in Review

Barclays sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 881,402 shares — an estimated $78.5M sold.

Barclays first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $78.5M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Barclays reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Barclays sold 881,402 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $78.5M.
  • Barclays first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Barclays's Mead Johnson Nutrition Company position peaked at $78.5M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.